Rheumatology Doctors in Peoria, AZ Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Dr. Ravi Bhalla, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13943 N. 91st Ave, Building I, Peoria, AZ 85381 Phone: 623-815-2690    Fax: 623-815-2689

Orwah Al-khalili, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 6818 W Thunderbird Rd, Peoria, AZ 85381 Phone: 623-566-3550    Fax: 623-566-3573

Mr. Varun Bhalla, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13943 N 91st Ave, Bldg 1, Peoria, AZ 85381 Phone: 623-815-2690    Fax: 623-815-2689

Joy Schechtman, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6818 W Thunderbird Rd, Peoria, AZ 85381 Phone: 623-209-7831    Fax: 623-566-3573

News Archive

Oral contraceptive pills have negative impact on women's quality of life, study shows

One of the most common combined oral contraceptive pills has a negative impact on women's quality of life but does not increase depressive symptoms.

DSM Biologics partners with Australian Governments to build cGMP mammalian CMO

DSM Biologics is pleased to announce the signing of preliminary agreements to enter a partnership with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate the first major Australia-based mammalian biopharmaceutical manufacturing facility, which will be located in Brisbane.

In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles

In an attempt to determine what factors make one nanoparticle better than another at targeting tumors, a team of investigators in Korea have conducted a systematic tumor-targeting study of a variety of self-assembling nanoparticles.

Study shows long-term effect of vitamins and calcium supplements in breast cancer reduction

Vitamins and calcium supplements appear to reduce the risk of breast cancer, according to findings presented at the American Association for Cancer Research 101st Annual Meeting 2010.

Investigational drug may reduce protein buildup and neurological decline linked to ALS, FTD

An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic.

Read more Medical News

› Verified 2 days ago